Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neoplasm with neuroendocrine differentiation that arises from the colon. It includes well differentiated neuroendocrine tumors (low and intermediate grade) and poorly differentiated neuroendocrine carcinomas (high grade).
Biomarker and diagnostic research for colon neuroendocrine neoplasm has been reported in the published literature.
No clinical trials have been registered for colon neuroendocrine neoplasm.
106 publications have been identified in PubMed for colon neuroendocrine neoplasm. Research spans Review / Meta-Analysis (38%), Clinical Trial Publication (26%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 40 | 38% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:01 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about colon neuroendocrine neoplasm
28 |
26% |
Testing and diagnosis research | 14 | 13% |
Disease patterns and progression | 13 | 12% |
Laboratory research | 6 | 6% |
Patient case studies | 4 | 4% |
New treatment approaches | 1 | 1% |
Tanguy R (2026). [PMID: 42115465](https://pubmed.ncbi.nlm.nih.gov/42115465/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
van den Heerik ASVM (2026). [PMID: 41449145](https://pubmed.ncbi.nlm.nih.gov/41449145/). *Lancet Oncol*. [Clinical Trial Publication]
Nilsson P (2026). [PMID: 41655576](https://pubmed.ncbi.nlm.nih.gov/41655576/). *Lancet Oncol*. [Clinical Trial Publication]
Sheng YH (2026). [PMID: 41693974](https://pubmed.ncbi.nlm.nih.gov/41693974/). *World J Gastroenterol*. [Review / Meta-Analysis]
Cella L (2026). [PMID: 42041162](https://pubmed.ncbi.nlm.nih.gov/42041162/). *Future Oncol*. [Review / Meta-Analysis]
Leung WK (2026). [PMID: 41057234](https://pubmed.ncbi.nlm.nih.gov/41057234/). *Gut*. [Review / Meta-Analysis]
Brat DJ (2026). [PMID: 42152226](https://pubmed.ncbi.nlm.nih.gov/42152226/). *Neuro Oncol*. [Clinical Trial Publication]
Hou G (2026). [PMID: 41134321](https://pubmed.ncbi.nlm.nih.gov/41134321/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Su J (2026). [PMID: 41653198](https://pubmed.ncbi.nlm.nih.gov/41653198/). *Cancer Immunol Immunother*. [Review / Meta-Analysis]
Virata MC (2026). [PMID: 41903203](https://pubmed.ncbi.nlm.nih.gov/41903203/). *Neuro Oncol*. [Basic Science / Preclinical]